Abstract We evaluated the extent to which anatomic barriers to vector penetration might influence the distribution of successful in vivo gene transfer into the normal arterial wall. A double-balloon catheter technique with infusion pressures of 100 to 400 mm Hg was used to infuse microscopic tracer particles of the size range of liposomes and viral vectors into normal elastic arteries of sheep. Localization of the tracer particles in tissue sections by light, fluorescence, and electron microscopy suggested that vector-sized particles were delivered to the intima by direct infusion and to the adventitia via the arterial vasa vasorum. Particles were virtually absent from the arterial media. To test the predictions made from the particle studies, we repeated the infusion protocol with high-titer adenoviral vectors. Gene transfer occurred at high levels in the intima and along the adventitial vasa vasorum but again was virtually absent within the media. The ability of medial smooth muscle cells to be transduced was established in separate experiments with a high-pressure (5 atm) porous balloon infusion catheter. We conclude that (1) the anatomy of the normal elastic arterial wall imposes significant limitations on the penetration of particles in the size range of most gene-transfer vectors and (2) the distribution of in vivo gene transfer with adenoviral vectors is correctly predicted by the distribution of inert tracer particles. These findings have important implications for the design of arterial gene-transfer and gene-therapy protocols.
T he large elastic arteries are common sites of atherosclerotic and thrombotic disease. Recent reports of direct in vivo gene transfer into the walls of elastic arteries have suggested that in vivo gene transfer may be a powerful technique both for the delivery of local therapeutic gene products within the arterial wall and for modeling the role of individual genes in vascular pathophysiology. In vivo arterial gene transfer with both marker genes and genes of biological interest has been reported by several groups. 1 " 7 Although the feasibility of in vivo arterial gene transfer is currently accepted, it has also become apparent that with the possible exception of adenoviral vectors, the commonly used methods of in vivo arterial gene transfer are extremely inefficient. 8 In addition, use of these vectors may not result in gene transfer into all layers of the arterial wall. In previous work with retroviral vectors, we estimated that fewer than 100 cells (or approximately 1 in 10 4 to 1 in 10 5 cells) were transduced after injection of high-titer retroviral vectors into rabbit aortas by means of a perforated balloon catheter. Transduced cells were not specifically localized. 3 Leclerc et al, 4 using liposome-mediated transfection and a two-catheter system, have estimated the upper limit of the frequency of gene transfer into rabbit iliofemoral arteries at fewer than 1 in 1000 cells, with no lower limit. Transduced cells were limited to the neointima. 4 Other groups have reported detection of arterial gene transfer only by using the extremely sensitive luciferase reporter gene, 2 -9 which is capable of detecting expression in fewer than 1 cell in 10 000. 10 No specific localization of transduced cells has been provided in these studies. A recent report of adenoviral vectormediated gene transfer into sheep carotid arteries demonstrated a high efficiency of in vivo gene-transfer; however, this high efficiency appeared to be limited to a monolayer of luminal endothehum. 5 In considering potential reasons for the observed low efficiency and incomplete distribution of arterial gene transfer, it is useful to consider the three steps that must occur sequentially for in vivo gene transfer to succeed: (1) The genetic material must be delivered to the target cells. ( 2) The genetic material must be taken up by the cells. ( 3) The genetic material must be expressed by the cells. Inefficiency at any of these steps will prevent high-efficiency gene transfer. Elucidation of which step is inefficient may both clarify the limitations of gene transfer as well as suggest possible means by which arterial gene-transfer efficiency may be improved.
We considered whether the impediment to efficient in vivo gene transfer throughout the arterial wall might reside in a low efficiency of delivery of genetic material to the targeted vascular cells. The permeability of the arterial wall to both macromolecules (eg, horseradish peroxidase [HRP] , with a molecular diameter of approximately 2 to 6 run" 12 ) and plasma lipid particles such as low-density lipoprotein (LDL; diameter, 22 to 24 run 13 ) has been studied extensively. 12 - 1415 A review of these studies suggests the presence of physical barriers to penetration of the vessel wall by particles of the size of currently employed gene-transfer vectors. Specifically, on the basis of these studies with smaller particles, neither cationic Hposomes (diameter approximately 250 nm 16 ) nor viral vectors (diameter approximately 100 nm 1718 ) would be expected, at either physiological or mildly supraphysiological pressures, to penetrate significantly through the layers of elastic laminae, matrix, and smooth muscle cells that compose the walls of large elastic arteries. 19 The results of recent studies with adenoviral vectors also suggest that a significant anatomic barrier to the penetration of viral particles into the vessel wall is present at the level of the subendothelium. 5 Despite these theoretical concerns regarding the permeability of the arterial wall to gene-transfer vectors, the extent to which the physical barriers of the arterial wall might interfere with the penetration of gene-transfer vectors and thereby limit the efficiency of certain in vivo arterial gene-transfer protocols has not yet been addressed.
In the present study we attempted to define the distribution of particles in the size range of Hposomes and virions after attempted infusion of these particles into the wall of sheep elastic arteries by the doubleballoon catheter. 1 -20 Light microscopy, fluorescence microscopy, and transmission electron microscopy were used to localize the particles after infusion. These initial studies suggested significant anatomic limitations to particle penetration. To test the predictive value of these findings, we repeated the infusion protocol by using the most efficient gene-transfer reagent available: high-titer recombinant adenoviral vectors. The distribution of in vivo gene transfer was analyzed by histochemical analysis and compared with the predictions made from the particle penetration studies.
Methods

Animals
All animal procedures were approved by the Animal Care and Use Committee of the National Heart, Lung, and Blood Institute. A total of 22 male and female sheep weighing 25 to 35 kg were used for these experiments. One day before catheterization each animal received a single oral dose of 650 mg aspirin. On the day of catheterization, anesthesia was induced with an intravenous dose of 0-5 mL/kg of 5% sodium pentothal. After endotracheal intubation, general anesthesia was maintained with isoflurane. At the completion of the studies, the animals were killed by an intravenous injection of 40 mEq KC1. For short-term particle-penetration studies, the animals were killed on the day of infusion. For adenoviral vector gene-transfer studies, the animals were killed on day 3 after gene transfer.
Catheterization Procedures (Double-Balloon Catheter System)
In all animals both common carotid arteries were surgically exposed, and in 8 the right femoral artery was also exposed. In each of these vessels, all arterial side branches for a length of 5 to 10 cm were identified, doubly ligated, and divided. A left femoral artery cutdown was performed, 200 U/kg sodium heparin was administered intravenously, and a 9F sheath was advanced into the left femoral artery. Through the sheath a 9F giant-lumen guiding catheter (Medtronic, Danvers, Mass) was advanced into one of the carotid arteries. Five millilitcrs of Angiovist intravenous contrast material (Burlex, Wayne, NJ) was injected by hand through the guiding catheter and recorded at 60 frames/s with a Phillips 7-in. x-ray image intensifier on film and videotape. A 1-cm measuring grid was placed on the neck of each animal and was similarly recorded. The diameter of the carotid artery was measured from the video image of the cineangiogram, and a magnification correction factor was determined by measuring the image of the grid.
To deliver particles to the vessel lumen, we used a doubleballoon infusion catheter 20 (USCI, Billerica, Mass) with a 3-cm spacing between the balloons (Fig 1) . This catheter design consists of two occluding balloons separated by a 3-cm-long space into which solutions can be infused via a specific catheter port. We chose the double-balloon catheter for the principal phase of these studies rather than the Wolinsky perforated-balloon catheter 3 -21 to optimize the conditions for in vivo gene transfer while minimizing the destruction of vascular tissue. The Wolinsky catheter was used, however, for specific control experiments as described below.
We considered the double-balloon catheter to be a potentially more optimal gene-transfer tool, as it both permits prolonged contact of a gene-transfer reagent with the vessel wall and avoids exposing the vessel to potentially destructive high-pressure streams. We wanted our results to be applicable to the efficiency problems encountered by these groups. Finally, others have claimed that use of the double-balloon catheter with adequate infusion pressure (169 to 208 mm Hg) allows delivery of either retroviral vectors or liposomes to all layers of the vessel wall. 23 The tracer used in these studies, however, was a radiolabeled plasmid, which is significantly smaller than either liposomes or virions. In more recent studies, documentation by immunohistochemistry of significant gene transfer and expression in the vascular media was complicated by cross-reactivity between the human transgene and the endogenous porcine molecule. 6 We desired to perform a more direct test of the hypothesis that liposome-or virion-sized particles could easily traverse the arterial wall.
The double-balloon catheter was employed as described.
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After inflation of the balloons to occlude blood flow, solutions were introduced into the space between the balloons. These solutions remained in contact with the vessel wall for as long as the occluding balloons were inflated. In the present experiments the double-balloon catheter was advanced through the guiding catheter to the previously exposed segment of the carotid artery. Each of the two occluding balloons of the infusion catheter was inflated with 0.5 mL normal saline, resulting in a pressure within the balloons of approximately 05 to U atm, as measured on a balloon inflation device (USCI). After isolation of the vessel segment by inflation of the occluding balloons, the lumen was flushed five times with 0.6-mL volumes of normal saline, resulting in a blood-free appearance of both the segment and the flush solution. During the experiments continuous arterial and infusion lumen pressures were monitored by the use of pressure transducers attached to both the fluid-filled guiding catheter and the infusion port of the double-balloon catheter. Pressures were recorded on an 8-channel physiological recorder (Gould Electronics, College Park, Md) at a scale of 0 to 500 mm Hg.
To test the effect of a relatively severe balloon injury on the consequent penetration of particles into the vessel wall, in certain of the vessels a balloon angioplasty catheter (USCI) was used to dilate the exposed carotid artery segment for a single 30-second inflation at 5 to 10 atm. After angioplasty the double-balloon catheter was positioned astride the site of the angioplasty balloon inflation. Angioplasty catheters varied from 5 to 8 mm in diameter and were chosen to be 1.5 to 2 times the original vessel diameter on the basis of angiographic measurement of the vessel as described above. A total of 15 vessels were subjected to balloon angioplasty according to this procedure.
After positioning of the double-balloon catheter and rinsing of the lumen, solutions of either colloidal carbon, fluorescent latex spheres, HRP, or adenoviral vectors were infused into the space between the occluding balloons. Preparation of the individual solutions is described below. Each solution was infused until a luminal pressure of 400 mm Hg was achieved, which required 0.4 to 0.6 mL infusate. After the initial infusion the pressure in the infusion space gradually decreased, presumably due to either a small amount of runoff or an increase in vessel compliance. To maintain the infusion pressure between 100 and 400 mm Hg for 30 minutes, we intermittently added 100 to 200 jiL of the infusate to the catheter lumen. A mean of 6 (range, 2 to 12) of these reinfusions were performed per vessel to maintain pressure. We chose a pressure range of 100 to 400 mm Hg, as this range has been shown by Goldman et al 20 to allow full penetration of the vessel media and partial penetration of the adventitia by HRP. Therefore, HRP could be used as a positive control for penetration of a relatively small particle (2 to 6 nm 11 ' 12 ) in this system. In addition, Nabel et al 23 have reported in vivo gene transfer throughout the thickness of the vessel wall with the use of an intraluminal pressure of approximately 150 to 200 mm Hg and have cautioned against the failure of gene transfer when using "suboptimal pressure." Thirty minutes after the initiation of infusion, the infusate remaining in the vessel lumen was aspirated, resulting in temporary collapse of the vessel lumen. The location of infusion was marked by placing surgical clips in the tissue adjacent to the artery, the catheter balloons were deflated, and the infusion catheter was removed. The guiding catheter was withdrawn to the brachiocephalic trunk, and the contralateral carotid artery was entered with the aid of a soft-tipped guide wire. Angiography and infusion procedures were repeated in this vessel. In 8 animals the guiding catheter was positioned in the right femoral artery and the procedures repeated in this location.
Catheterization Procedures (Wolinsky Catheter System)
To provide controls to address the issue of transducibility of arterial smooth muscle cells in vivo, in 2 additional sheep a Wolinsky infusion catheter (USCI) was used to deliver adenoviral vectors into the vessel wall. Surgical and catheter introduction procedures were virtually identical to those described above. In one of the sheep, vectors were infused into both carotid arteries. In the second sheep, vectors were infused into both femoral arteries, with vascular access obtained via the left carotid artery. In both cases infusion was performed without prior balloon angioplasty.
Infusion of Colloidal Carbon (India Ink) Particles
India ink is a colloidal-carbon suspension of particles with a size range of 120 to 500 run. 24 This size is similar to that of cationic liposomes, 16 
Infusion of Fluorescent Latex Spheres
To model the penetration into the vessel wall of particles of a diameter approximately 100 nm or less, we purchased fluorescent-labeled carboxylate-modified latex spheres (FluoroSpheres; Molecular Probes, Inc, Eugene, Ore). Fluorescent latex spheres in this size range have been used as in vivo tracers in the central nervous system. 25 These spheres possess the unique property of being visible as single particles by fluorescence microscopy despite having a diameter that is greater than one log unit less than the limit of light-microscopic resolution. 26 In the initial experiment with fluorescent spheres we injected a mixture of 30-and 93-nm-diameter spheres (fluorescein-and rhodamine-labeled, respectively). Because in this initial experiment the two sizes of spheres appeared to colocalize and we were interested in modeling the behavior of particles close in size to adenoviral and retroviral virions (65 to 80 and 100 nm, respectively 17 -1 "), the remainder of the experiments were performed with the 93-nm-diameter spheres only.
To minimize any possible aggregation of the latex spheres, the initial suspension as obtained from the manufacturer (2.05% solid latex spheres) was diluted in a solution of 1 part phosphate-buffered saline, pH 7.2 (Biofluids, Rockville, Md), and 2 parts water containing 1% bovine serum albumin to a final latex sphere concentration of 0.025%. Approximately 2 hours before use the suspension was centrifuged for 30 minutes at 15 OOOg. Only the supernatant was used for infusion, and this supernatant was vortexed for 30 seconds immediately before introduction into the catheter. The latex sphere suspension was infused into 4 uninjured and 4 balloon-injured carotid arteries in a total of 5 sheep. As controls for nonspecific autofluorescence, 2 femoral arteries and 1 carotid artery (all without balloon angioplasty) were infused with normal saline.
Infusion of HRP
Type II HRP (Sigma Chemical Co, St Louis, Mo) was dissolved in normal saline to a concentration of 10 mg/mL. This solution of HRP was infused into 4 uninjured carotid, 2 uninjured femoral, and 3 balloon-injured carotid arteries in a total of 6 sheep. As controls for any endogenous peroxidase activity in either normal or injured vascular tissues, 4 uninjured arteries (3 femoral and 1 carotid) were infused with normal saline, and 2 carotid arteries were balloon injured but not exposed to infusion via the double-balloon catheter method.
Infusion of Adenoviral Vectors
Stocks of an adenoviral vector expressing a nuclear-targeted -galactosidase gene or a cystic fibrosis transmembrane conductance regulator cDNA from a Rous sarcoma virus promoter were a kind gift of Dr Bruce Trapnell (Genetic Therapy Inc, Gaithersburg, Md). The construction of the vector and production of these vector stocks are described separately. 27 Titers of the viral stocks used were 10 10 to 10" plaque-forming units per milliliter. Adenoviral vectors were infused through the double-balloon catheter into 5 carotid arteries in 3 sheep. As controls, diluent was infused into 1 carotid and 1 femoral artery of each of these 3 sheep, and the cystic fibrosis transmembrane conductance regulator vector was infused into 2 carotid arteries of 1 sheep. All adenoviral vector studies were performed on uninjured vessels.
We chose adenoviral vectors for the present experiments, as these agents are capable of achieving gene transfer with nearly 90% efficiency in cultured human endothelial cells with a single incubation. 28 Studies in our own laboratory with cultured sheep endothelium and arterial smooth muscle cells have demonstrated nearly 100% and 80% efficiency of gene transfer, respectively, within 1 hour (data not shown). These in vitro results are superior to those we have achieved with a protocol optimized for retroviral vectors 29 and suggest that for short-term in vivo vascular gene-transfer studies, adenoviral vectors may currently be the more optimal reagent. Use of the nuclear-targeted /3-galactosidase reporter gene allows identification of individual transduced cells by both gross observation and microscopic sectioning. In this respect this reporter gene is superior to luciferase, the use of which has until present required destruction of target tissue to obtain a cell lysate for documentation and quantification of gene expression. The potential for quantification of gene expression in tissue extracts exposed to recombinant adenoviral vectors also exists for nuclear-targeted 0-galactosidase.
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Within 2 hours of an animal experiment, frozen aliquots of virus stocks were thawed and diluted in M-199 medium to a concentration of 5xlO 7 to 5x10* plaque-forming units per milliliter. In 3 of 4 experiments 2% fetal calf serum was included in the diluent. Infusion of the virus through the double-balloon catheter was performed via the same protocol used for the particle infusions into uninjured vessels, as described above. Infusion of the virus through the Wolinsky catheter was performed by injecting 4 to 5 mL of virions (diluted to 5 x 10 8 plaque-forming units per milliliter in M-199 medium with 2% fetal calf serum) at a pressure of approximately 5 atm (4000 mm Hg).
To allow time for DNA incorporation, transcription, translation, and accumulation of the /3-galactosidase enzyme, the sheep were allowed to recover after adenoviral vector-mediated gene transfer and returned to a holding area. Daily oral doses of 650 mg aspirin were given. Three days after the virus infusion the sheep were reanesthetized and the vessels surgically exposed for vessel harvest as described below. After vessel harvest the sheep were killed by potassium chloride injection.
Fixation and Removal of Vessel Segments
For HRP, colloidal carbon, and adenoviral vector infusion experiments, perfusion fixation was carried out in situ. Sheep were hemodiluted by bleeding 2 to 3 L from the arterial catheter with a simultaneous intravenous infusion of an equal volume of normal saline. The animals were then killed by potassium chloride injection. To clear the arterial tree of blood, 1 L normal saline was perfused through an arterial cannula at a pressure of 100 mm Hg. After clearing of the arterial tree, the fixatives were infused, consisting of: (1) 10% formalin for colloidal carbon; (2) 2% formaldehyde and 2% glutaraldehyde in 0.1 mol/L cacodylate buffer, pH 7.4, for HRP-infused vessels; or (3) 2% formaldehyde and 0.2% glutaraldehyde in phosphate-buffered saline for adenoviral vector-infused vessels. Fixatives were perfused through the arterial cannula at 100 mm Hg for 10 minutes. For fluorescentmicrosphere experiments (in which frozen sections were used), animals were killed without perfusion fixation. In all animals the vessels to be studied were ligated proximal and distal to the marked segments and excised. In the short-term particlepenetration studies (colloidal carbon, latex spheres, and HRP), the total time from infusion into the first carotid artery until removal of the arteries varied from 1.5 to 3 hours.
Histochemical and Histological Analyses of Infused Vessel Segments
A variety of microscopic and histological methods was used to evaluate penetration of each type of particle. Colloidal-carbon penetration was evaluated with light microscopy, fluorescentsphere penetration with both fluorescence and transmission electron microscopy, and HRP penetration with light microscopy, histochemistry, and transmission electron microscopy. Fluorescent-sphere size was also examined by transmission electron microscopy. Adenoviral vector-mediated gene transfer was evaluated by histochemistry with both gross observation of vessel segments and light microscopy of tissue sections.
Fixed, excised arterial segments that had been infused with colloidal carbon and the corresponding control segments were cut into 5-mm rings, dehydrated, embedded in paraffin, sectioned at 6 fim, mounted on glass slides, and stained with hematoxylin and eosin. Light microscopy was used to examine sections from arteries infused with colloidal carbon and the corresponding controls. Six to 18 sections from each vessel were evaluated for the presence of black colloidal carbon in the intima, media, and adventitia. A section was recorded as positive for penetration into a vessel layer if any carbon particles were observed in that layer.
Excised arterial segments that had been infused with fluorescent spheres and their corresponding controls were rinsed in normal saline, cut into 5-mm rings, and frozen in OCT compound (Miles Scientific, Naperville, 111). These rings were later frozen sectioned, mounted on slides, and stored in light-tight containers at -20°C. Sections were viewed under a Nikon fluorescence microscope with standard rhodamine excitation at x 100 to x400 magnification. Six to 20 sections from each vessel were evaluated for the presence or absence of bright, punctate fluorescence in the intima, media, and adventitia. In a manner identical to the protocol for determination of colloidal-carbon penetration into the vessel layers, a section was recorded as positive for penetration into a particular vessel layer if any punctate fluorescence (thought to be due to the presence of latex spheres rather than nonspecific background fluorescence) was observed in that layer.
A 3-mm segment was cut from one carotid artery that had been infused with 93 -nm fluorescent spheres. This segment was fixed in 3% glutaraldehyde, transferred to 1% OsO, in 0.1 mol/L sodium cacodylate buffer, pH 7.4, dehydrated, and embedded in Epon. Semithin sections were cut, stained with toluidine blue, and examined by light microscopy. The area with the most capillaries in the adventitia, as well as areas of the media and intima, were selected for ultrathin sectioning. These sections were stained with uranyl acetate and lead citrate and examined with a Zeiss 109 IGF electron microscope. In addition, to confirm the size of the latex spheres, a sample of the suspension of 93-nm fluorescent spheres was allowed to dry and examined by transmission electron microscopy.
Fixed, excised segments from vessels infused with HRP and companion controls were processed for histochemical detection of HRP. Arterial segments were prepared as described for detection of HRP in myocardial tissue. 31 Briefly, excised vessels were fixed in 2% glutaraldehyde and 2% formaldehyde in 0.1 mol/L sodium cacodylate buffer, pH 7.4, for 5 to 6 hours at room temperature followed by overnight washing in 0.1 mol/L sodium cacodylate buffer containing 11% sucrose at 4°C. Arteries were cut at 2-mm intervals and embedded in OCT compound. A whole-mount 8-^im frozen section was cut from each arterial segment. To develop the HRP reaction product, frozen sections were incubated for 5 minutes at room temperature in 0.05 mol/L tris(hydroxvmethyl)aminomethane (Tris) buffer, pH 7.6, with 1 mg/mL 3-3'-diaminobenzadine tetrahydrochJoride (Sigma) and 0.01% H 2 O 2 . Sections were counterstained with hematoxylin and examined by light microscopy. Six to 18 sections from each vessel were evaluated for the presence of brown-staining HRP reaction product in the intima, media, and adventitia in a manner identical to that used for colloidal carbon.
The HRP reaction product was identified by electron microscopy according to the following protocol. In three vessels, sections approximately 50 /im thick were cut and incubated for 1 hour in Tris buffer containing 1 mg/mL 3-3'-diaminobenzadine tetrahydrochloride and 0.01% H 2 O 2 . Tissues were then postfixed in ferrocyanide-reduced 1% OsO 4 in Palade buffer, pH 7.4, containing 4.9% sucrose for 90 minutes at 4°C, processed by hand in graded ethanol, and embedded in Epon. Sections of micron thickness were cut and examined by light microscopy for the presence and location of the HRP reaction product. Further thin sectioning for electron microscopy was performed on areas that stained positively for the HRP reaction product. A total of three thin sections from each of the three vessels was examined by transmission electron microscopy.
Excised arterial segments from vessels infused via the doubleballoon catheter with adenoviral vectors (and companion controls) were processed for histochemical detection of nucleartargeted /}-galactosidase. Briefly, after perfusion fixation and excision, segments were rinsed once in 1 mmol/L MgCl 2 in phosphate-buffered saline, opened longitudinally with two incisions, and submerged in a solution of 5-bromo-4-chloro-3-indoh/l-/3-D-galactopyranoside (X-Gal) as described previously 32 -33 for 3.5 hours. After X-Gal staining the vessel segments were returned to 1.25% glutaraldehyde in 0.1 mol/L cacodylate buffer, pH 7.4, and stored at 4°C. The stained specimens were examined and photographed through a Zeiss dissecting microscope. After being photographed, each arterial specimen was cut into serial segments approximately 2 mm long. To minimize sampling errors in examining microscopic sections, the serial segments taken from a single vessel were aligned alongside each other and embedded in a single paraffin block. Microtome sections of these blocks therefore typically contained tissue sections from 8 to 10 evenly spaced areas of the vessel. The microtome sections were further stained with histological stains, including eosin only, hematoxyiin and eosin, and nuclear fast red, and were examined by light microscopy for the presence of deep blue nuclei suggestive of /3-galactosidase expression.
During examination of tissue sections, cells were identified as endothelial by their location either luminal to the internal elastic lamina of the vessel proper or along the lumens of vascular spaces in the adventitia. Endothelial cell identity was confirmed by immunohistochemistry with an antiserum to human von Willebrand factor (Dako, Carpinteria, Calif; data not shown). The presence of vascular endothelium in areas of blue staining was further confirmed by scanning electron microscopy (data not shown). Cells were identified as smooth muscle cells both by their location below the internal elastic lamina and by their characteristic spindlelike morphology with elongated nuclei. Smooth muscle cell identity was confirmed by immunohistochemistry with a monoclonal antibody to human smooth muscle cell a-actin (Sigma; data not shown).
The vessels infused with adenoviral vectors via the Wolinsky catheter were processed, stained, photographed, and sectioned in a manner identical to that described for the doubleballoon-infused vessels.
Results
Histological Examination of Vessels Instrumented With the Double-Balloon Catheter
Sections from vessels infused with particles in the absence of balloon angioplasty were examined histologically to evaluate the presence of vascular injury consequent to the double-balloon infusion protocol. Vessels infused with colloidal carbon were stained with hematoxylin and eosin as well as Movat's stain. The integrity of the intima and media was largely preserved; however, we did observe occasional endothelial denudation and subendothelial injury as evidenced both by focal loss of smooth muscle cell cytoplasmic staining and by pyknosis and fragmentation of smooth muscle cell nuclei (data not shown). HRP-infused vessels exhibited similar evidence of mild focal vascular injury. Latex sphereinfused vessels were examined as frozen sections, with the morphology insufficiently preserved to evaluate the presence of focal injury.
Histological examination of sections from angioplasty balloon-injured vessels revealed far more severe injury with frequent disruptions of the internal elastic lamina and accompanying microdissections into the vascular media. Extensive medial injury (identified as described above) was present in all vessels examined. In summary, while balloon angioplasty produced extensive injury, delivery of the various particles through the doubleballoon catheter also resulted in low levels of intimal and medial injury.
Tissue Distribution of Colloidal Carbon Infused by the Double-Balloon Catheter
Filtered colloidal carbon (approximately 150 to 450 nm) was infused into 10 carotid arteries, 6 with prior injury by balloon angioplasty and 4 uninjured vessels. In both injured and uninjured vessels, the highest concentration of particles was located along the luminal surface of the intima (Table and Fig 2A) . Intimal carbon was found in 36 of 51 sections (71%) from uninjured arteries and in 50 of 72 sections (69%) from ballooninjured arteries. Colloidal-carbon particles were also found frequently in the adventitia (Table and Fig 2C  and 2D) . Fifteen of 51 sections (29%) from uninjured vessels contained some adventitial colloidal carbon, as did 14 of 71 sections (19%) from injured arteries. Adventitial colloidal-carbon particles were often observed within the vasa vasorum, which occasionally were completely filled with the black particles (Fig 2D) . Sections containing adventitial carbon particles often contained no particles in the intima or media (Fig 2C  and 2D) , suggesting that the particles did not arrive in the adventitia either by diffusion or by other means of direct penetration through the layers of the vessel wall. Similarly, with a single exception described below, sections of vessels with colloidal carbon in the intima (Fig  2A) never contained carbon in the media and only occasionally contained carbon in the adventitia, again indicating that direct penetration of these particles through the layers of elastic laminae and smooth muscle cells did not occur in this local infusion model.
Colloidal carbon was found in the media of only 3 of 72 sections (4%; all from the same vessel). In this one instance the particles were confined to the false lumen of a microdissection in a balloon-injured artery ( Fig  2B) . In this vessel in which penetration through the internal elastic lamina occurred secondary to mechanical disruption, there was no evidence of diffusion or any other means of dispersion of the particles through the vessel wall. In summary, colloidal-carbon particles were found virtually exclusively in the intima and adventitial vasa vasorum in both injured and uninjured vessels. 
Tissue Distribution of Latex Spheres Infused by Double-Balloon Catheter
Fluorescent-labeled 93-nm-diameter latex spheres were infused into 8 carotid arteries, 4 with prior injury by balloon angioplasty and 4 uninjured vessels. On examination of frozen sections of both experimental and control vessels with the fluorescence microscope, faint autofluorescence was observed, particularly in the adventitia (Fig 3) . In addition to this background, areas of very bright, punctate fluorescence were seen in vessels into which fluorescent spheres had been infused ( Fig  3A) . These brightly fluorescent punctate areas resembled the appearance of the latex spheres when viewed in suspension with fluorescence microscopy (not shown). This pattern of fluorescence was virtually never seen in sections of control vessels into which the fluorescent spheres had not been infused. We therefore interpreted these areas to represent the location of infused spheres.
Fluorescent spheres were found in the intima of virtually all sections examined. Spheres were found in the intima of 59 of 60 sections (98%) from uninjured vessels and in 38 of 44 sections (86%) from injured arteries (Table) . As with the colloidal carbon, the 93-nm spheres were virtually absent from the media. Very rare fluorescent spots were seen in the media in 3 of 60 sections (5%) from uninjured vessels and 1 of 44 sections (2%) from injured vessels. In contrast to their nearly complete absence within the media, fluorescent spheres were often observed in abundance within the adventitia (Fig 3A) . Spheres were seen in the adventitia in 28 of 60 sections (47%) from uninjured vessels and 24 of 44 sections (55%) from injured arteries (Table) . Within the adventitia, spheres were seen most commonly in the outer adventitial layers (Fig 3A) , an area that corresponds to the location of the majority of the vasa vasorum (Fig 2A, 2C, and 2D ). In summary, as with the larger colloidal-carbon particles, 93-nm latex spheres infused via the double-balloon catheter were found virtually exclusively in the intima and adventitia regardless of prior balloon injury. This discontinuous distribution of the spheres suggests both that the vessel wall is relatively impermeable to these particles and that access of the spheres to the adventitia is by means other than direct penetration through the layers of the vessel wall.
To establish further the size and location of the latex spheres, transmission electron microscopy was performed on both a suspension of the spheres and a segment of uninjured vessel into which the spheres had been infused (Fig 5) . The in vitro study confirmed that the spheres existed as a suspension of independent particles approximately 100 nm in diameter (Fig 5A) . Photomicrographs of vessel sections revealed the presence of numerous circular objects, up to approximately 100 nm in diameter, either within or adjacent to endothelial cells that line the capillaries of the adventitial vasa vasorum (Fig 5B and 5C ). These circular objects consisted of a lucent center surrounded by a more electron-dense ring, which may reflect the presence of a coating of either fluorescent dye, albumin, or the carboxylate surface modification (see "Methods") of the spheres. The objects were often smaller but never larger than approximately 100 nm, suggesting again that they represented spheres, some of which were cut in nonequatorial planes. In the sections examined, no similar spherical objects were observed in either the media or intima. The transmission electron photomicrographs therefore confirmed the size and monodispersion of the latex spheres and further documented the presence of the spheres in the adventitia, in close proximity to the endothelial cells of the vasa vasorum. The relative abundance of the spheres in the adventitia as well as their absence in the other vessel layers again argues against direct penetration of the infused spheres through the layers of the vessel wall.
Tissue Distribution of HRP Infused by the Double-Balloon Catheter
We further investigated the permeability of the vessel wall by using a smaller tracer particle, the HRP molecule. HRP has a molecular diameter of approximately 2 to 6 nm, considerably less than either the colloidalcarbon particles or the latex spheres, which were intended to model liposomes and virions, respectively. HRP has been shown in previous studies to penetrate the full thickness of the arterial wall rather freely ) . B, Infusion after balloon angioplasty demonstrates particles contained within the false lumen of a dissection (original magnification x40). C, AdventJtial colloidal carbon within the vasa vasorum (original magnification x40). D, Same as C at x80. Lu indicates lumen; adv, adventitia. All sections were stained with hematoxylln and eosln and were taken from balloon-angioplastied vessels. ing any particles directly into the media of the vessel wall. HRP was infused into 4 carotid and 2 femoral arteries without prior balloon injury. Three carotid arteries were first balloon injured and then subjected to HRP infusion. Four uninjured arteries (3 femoral and 1 carotid) and 2 injured carotid arteries were infused with HRP diluent as a control. The HRP reaction product was detected in all layers of the vessel wall in a large majority of sections in both uninjured and ballooninjured vessels (Table and Fig 4) . In contrast to the intimal and adventitial distribution of the colloidalcarbon particles and latex spheres, virtually all vessel sections contained evidence of HRP penetration into the media (83% of uninjured and 100% of injured vessels). Further confirmation of HRP penetration into the media was obtained from transmission electron photomicrographs that demonstrated characteristic HRP reaction product 1114 between the smooth muscle cells of the vascular media (Fig 6) . The appearance and distribution of the HRP reaction product in the vessel was similar to that described in previous reports of the detection of HRP reaction product by electron microscopy.
11 ' 14 Data obtained with HRP therefore confirmed that small molecules can be infused via the doubleballoon catheter protocol, to penetrate directly through the intima into the media and adventitia. These data also suggest that the absence of carbon and fluorescent latex spheres in the vascular media after infusion of these particles via the same catheter system is due to their size rather than to any inherent limitations of the infusion protocol.
Tissue Distribution of Adenoviral Vector-Transduced Cells After Virion Infusion Through the Double-Balloon Catheter
To test the predictions made from the particle-distribution studies, adenoviral vectors were infused via the double-balloon catheter into 7 uninjured arteries in 3 sheep. Gross observation of vessel segments that had been exposed to the ^-galactosidase-expressing adenoviral vector and stained with X-Gal revealed blue dots along the luminal surface, often in impressive local abundance ( Fig  7A and 7B) . Because the vessels were divided longitudinally before staining, a view along a strip of vascular media was visible along both sides of a section (Fig 7C) . Only very rare blue dots were seen along these strips of vascular media, and these dots were clearly identified through the dissecting microscope as denuded cells floating above the tissue. In contrast to their absence on the media, blue dots suggestive of gene transfer and expression of /3-galactosidase were seen in the adventitia, both in cross section (Fig 7C) and along the abluminal vessel surface. When present on the abluminal surface, the blue dots were often located along the course of the vasa vasorum (Fig 7D) . In vessels with the most extensive blue staining in the adventitia, an ostium of a branch vessel was virtually always seen leaving the lumen of the vessel, adjacent to the areas of adventitial gene transfer (Fig 7E) . These branch vessels usually had blue dots visible within their lumens (Fig 7E) and were presumably the source of the vasa vasorum into which adventitial gene transfer occurred. In contrast, no blue dots were seen in vessels that were infused with medium only and stained with X-Gal in parallel with vessels exposed to the ^-galactosidase-expressing adenoviral vectors (Fig 7F) . Vessels infused with the vector expressing the cystic fibrosis transmembrane conductance regulator similarly contained no blue dots after X-Gal staining (not shown). When vessel segments were left in fixative for at least 1 to 2 days after X-Gal staining, however, both experimental and control vessels began to acquire a diffuse blue hue (not shown). We interpreted this blue appearance as nonspecific background staining, similar to that reported by both our group and others in the vessels of the rabbit, dog, and rat. 24 -8 This diffuse blue stain was easily distinguished from the pattern of distinct blue dots that was observed only in experimental vessels after the short (0.5 to 35 hours) periods of X-Gal staining used in the present study.
Microscopic examination of vessels exposed to thê -galactosidase-expressing adenoviral vectors via the double-balloon catheter and stained with X-Gal revealed deep blue-staining nuclei in three locations: (1) endothelial cells along the vessel lumen ( Fig 8A) ; (2) smooth muscle cells within one to two cell layers of the internal elastic lamina ( Fig 8B) ; and (3) cells in the adventitia, the vast majority of which appeared to be endothelial cells lining the vasa vasorum (Fig 8C) . Blue-stained nuclei were seen along both larger vasa vasorum (Fig 8C) and smaller adventitial capillaries (not shown). No blue nuclei were found in the vascular media beyond the first one to two layers of smooth muscle cells. Vascular injury, as evidenced by either endothelial denudation or medial necrosis (Fig 8B) , was almost always present adjacent to transduced smooth muscle cells. Microscopic examination of sections of control vessels revealed absolutely no deep blue staining of nuclei in any layer of the vessel wall ( Fig 8D) .
As an additional control to examine the possibility that confinement of blue staining to the intima and adventitia might be due to impaired diffusion of the X-Gal substrate into the fixed vessel segments, frozen sections of vessels transduced with the /3-galactosidase vector were subjected to staining by placement of the X-Gal substrate solution directly over the entire section. Several blue-staining cells were detected in these sections; however, none of these blue cells were in the vascular media. The lack of blue staining in the media of whole vessels submerged in X-Gal was therefore not likely to be a false-negative result due to failure of substrate diffusion.
Tissue Distribution of Adenoviral Vector-Transduced Cells After Virion Infusion Through the Wolinsky Catheter
As an additional control experiment to address the possibility that adenoviral vectors delivered by double- balloon catheter were penetrating into the media but not transducing smooth muscle cells, virions were infused into 4 arteries via the Wolinsky infusion catheter. In these arteries we found occasional macroscopic blue staining in a pattern corresponding to the distribution of holes in the catheter (Fig 9A and data not shown) . Microscopic sections of these vessels revealed endothelial loss, medial necrosis, and focal high-level transduction of smooth muscle cells throughout several layers of the media (Fig 9B) . These data confirm that the failure to transduce significant numbers of medial cells with the double-balloon catheter is not due to a resistance of sheep smooth muscle cells to in vivo adenovirai vectormediated gene transfer. More likely, the virions do not penetrate the media of a normal elastic artery to any significant extent unless either the endothelium is damaged or the virions are forcibly injected at very high pressures.
In summary, the results obtained with adenoviral vector-mediated in vivo gene transfer coincided very closely with the predictions made by the particle injections. With the double-balloon catheter and infusion pressures up to 400 mm Hg, high levels of gene transfer occurred in the intima, specifically into the luminaJ endothelium. A lower but still appreciable number of adventitial cells were also transduced. Gene transfer into the media occurred at extremely low levels and only immediately adjacent to the intima. As all major cell types of the vessel wall (luminal endothelial cells, smooth muscle cells, adventitial endothelial cells, and nonendothelial adventitial cells) were observed to have at least some level of recombinant gene expression, failure of gene transfer cannot be attributed to celltype-specific resistance to in vivo gene transfer, eg, as might result from absence of expression of a viral receptor or from failure of the Rous sarcoma virus promoter to function in a particular cell type. The distribution of transduced cells within the vessel wall suggests rather that in the absence of significant vascular trauma, such as that produced by the high-pressure Wolinsky catheter, virions have access only to the intima, the very innermost layers of the media adjacent Fig 7C) . B, Microscopic section of vessel through an area of blue staining. The vessel lumen (Lu) and adventitia (Adv) are Indicated. After X-Gal staining and paraffin embedding of the entire vessel, histologlcal sections were stained with nuclear fast red. Blue staining is localized to nuclei within the media The arrow indicates one of several areas of medial necrosis, with the absence of both nuclei and normal cytoplasmic staining (compare with Fig 8A and 8B) . Note also the complete loss of endothelium from the luminal surface. Panel A original magnification x6.4; panel B, x20.
to intimal injury, and the adventitia. Access of virions to the adventitia appears to occur strictly through the vasa vasorum and not through direct penetration of the vessel wall. Discussion A major objective of the present study was to investigate whether the anatomy of normal elastic arteries might serve as an impediment to high-efficiency in vivo gene transfer. Our results suggest that in the model system using the double-balloon catheter and infusion pressures between 100 and 400 mm Hg, arterial anatomy imposes significant constraints on the distribution of in vivo gene transfer. Both high-level particle delivery and gene transfer occur in the intima; however, the intima contains only a very small proportion of vascular cells. The media of the vessel wall, which contains a much larger proportion of vascular cells, appears to be virtually inaccessible to particles the size of gene-transfer reagents delivered by the double-balloon catheter protocol, irrespective of prior angioplasty balloon injury. The adventitia, which also contains a significant proportion of vascular cells, is apparently accessible to particles the size of gene-transfer reagents only through branches of the vasa vasorum, which in our specimens were present only irregularly along the length of the vessel wall. Thus, both adventitial particle delivery and gene transfer were in many cases patchy and occasionally completely absent in individual specimens. The only layer of the arterial wall into which both particle delivery and gene transfer occurred reliably was the intima.
The confinement of both particle delivery and gene transfer to the intima and adventitia as well as the accessibility of all layers of the arterial wall to the smaller HRP molecule are consistent with previously published data on arterial wall permeability. 13 ) into squirrel monkeys and measured transmural accumulation of LDL across blood vessel walls 30 minutes after injection. Steep concentration gradients were found from the intima outward, with LDL concentration in the media of many large arteries "generally near zero." 15 Occasional areas of increased vessel permeability to LDL were found, but these areas were rare and extremely small, on the size range of one to two endothelial cells. 15 Nievelstein et al 34 injected LDL into rabbits, and 2 hours after injection, found by electron microscopy that the LDL accumulated in the subendothelial space of the aorta and was trapped by a dense network of matrix filaments. Poiani et al 35 injected liposomes (measured at 100-to 220-nm diameter) into rats with experimentally induced pulmonary hypertension. Two hours after injection the liposomes were located within pulmonary artery endothelial cells and were found neither in the basement membrane nor in any nonendothelial cell types within the lung. The results of Poiani et al accord with the well-known inability of liposomes to penetrate the endothelium of most of the vasculature. 36 On the basis of these previous data, one would not expect particles of the size range of 90 to 450 nm (latex spheres and colloidal-carbon particles used in the present study) to penetrate freely through the walls of large arteries. Consistent with these data, in our experiments these particles did not directly penetrate the full thickness of the arterial wall. The smaller HRP molecule was shown to penetrate the arterial walls of rats and mice in the work of Florey and Sheppard, 14 and HRP also freely penetrated the sheep arteries in the present study. Taken together, these data suggest that the low efficiency of in vivo arterial gene transfer that has been observed in many studies published to date results at least in part from the existence of anatomic barriers to particle penetration of the vessel wall.
In contrast to the results obtained with arterial tissue, relatively efficient gene transfer into the intact liver has been reported (1% of total hepatocytes with the use of retroviral vectors and more than 95% with the use of adenoviral vectors).
37
- 38 Gene transfer into the intact renal glomerulus at a reasonable efficiency (10% to 15% of glomeruli) was also reported by Tomita et al 39 using a liposome-mediated technique. The reason for the apparently increased efficiency of gene transfer into these organs when compared with arterial tissue may well be anatomic, as the architecture of both the hepatic sinusoids and the renal glomeruli allows for the ready egress of large molecules from the vascular space. 4041 In contrast, large elastic arteries have evolved to serve as relatively impermeable conduits. Of note, a recent report of in vivo adenovirus-mediated gene transfer, into the airway suggests that anatomic barriers to the penetration of gene-transfer vectors also exist in the lung.
The results of the present study have important implications with regard to the cellular targets of in vivo gene transfer into normal elastic arteries. For in vivo gene-transfer protocols similar to ours (with gene-transfer reagents in the size range of 90 to 450 nm delivered intraluminally at normal or only modestly elevated pressure), one would anticipate reliable gene transfer into the luminal endothelium with relatively far fewer smooth muscle cells transduced. The vast majority of smooth muscle cells will not be successful targets of gene transfer. In addition, depending on the distribution of the vasa vasorum in a target vessel segment, variable adventitial gene transfer can be anticipated. Target cells in the adventitia will most likely be primarily the endothelial cells of the vasa vasorum.
In arterial gene-transfer protocols that do not include ligation of branch vessels (from which the vasa vasorum appear to originate in the sheep carotid artery; see Fig  7D and 7E) , one would anticipate little adventitial gene transfer, for the vectors would escape from the vessel via these branches rather than being forced to enter the vasa vasorum due to distal ligation of the branch vessels. In vessels that either have no vasa vasorum or contain vasa vasorum that originate from adjacent vessels, 42 we would anticipate no adventitial gene transfer with the protocol described in the present study. It will be interesting to note whether these predictions are borne out in future in vivo arterial gene-transfer studies.
The apparent anatomic limitation of cellular targets described herein has important implications for the suitability of this particular local gene-transfer model for both the study of vascular biology and certain approaches to arterial gene therapy. Gene-transfer protocols that envision intimal and/or endothelial gene transfer are reasonable to undertake with this model; protocols that depend on high-efficiency smooth muscle cell transduction may require either endothelial denudation or the use of a very-high-pressure injectate. With vascular gene-therapy protocols that depend on the delivery of a therapeutic gene product (rather than a gene per se) to the smooth muscle cells of the arterial wall, it is conceivable that molecules could be delivered from transduced cells located either in the intima or adventitia. Transport of labeled albumin into the arterial media from both the lumen and the adventitia has been demonstrated, 43 and successful delivery of antiproliferative agents (relatively small molecules such as heparin and oligonucleotides) to the media from the adventitia has also been described. 4445 On the basis of the report by Barger et al 4 * of the relative abundance of vasa vasorum in diseased versus normal human coronary arteries, the preferential expression of therapeutic genes from transduced cells in the vasa vasorum may actually prove advantageous for vascular gene-therapy protocols.
The limitations of our results should also be considered. First, we studied gene transfer into nondiseased elastic arteries. In humans, the anatomy of muscular arteries differs from that of elastic arteries. For example, muscular arteries have relatively small amounts of collagen and elastin fibers in the media when compared with elastic arteries. 19 Such anatomic considerations may affect the distribution of gene-transfer vectors within the vessel, such that gene transfer occurs in a different pattern from that found in the present study.
The anatomy of diseased vessels also varies significantly from that of their normal counterparts, and such variations will likely affect the distribution of gene transfer. Indeed, Leclerc et al, 4 using in situ hybridization, reported that liposome-mediated gene transfer into diseased rabbit arteries was limited to the neointima, an anatomic feature not present in normal vessels. The pattern of gene transfer into mechanically denuded vessels*- 27 is also likely to differ from that observed in a normal artery, if only for the obvious reason that the endothelium is removed before attempted gene transfer. In the present study a dependence of medial gene transfer on vascular injury was suggested (Figs 8C and  9B) . Confirmation of this dependence will require further experimentation.
In summary, in the current model the anatomy of the vessel wall appears to impose significant limitations on the pattern and extent of in vivo arterial gene transfer using the relatively low-pressure double-balloon catheter delivery system. Consideration of these limitations should allow the appropriate application of current gene-transfer protocols and may provide insights towards the development of novel approaches.
